By Roderick Law (Townhall)
Americans have long paid the highest drug prices in the world, while patients in Europe and Canada receive the same medicines for a fraction of the cost. The Trump administration’s TrumpRx initiative aims to correct that imbalance.
Last May, President Trump issued an executive order directing pharmaceutical companies to offer Americans “most-favored-nation” pricing – or the lowest price charged in other developed countries.
This order came with an ultimatum to major drug manufacturers that they would face “aggressive action” from the U.S. government should they not comply. While harsh, this was a much-needed check on the pharmaceutical industry charging Americans dramatically more than foreign nations to offset lower prices negotiated abroad.